Gene: DTX2
Official Full Name: deltex E3 ubiquitin ligase 2provided by HGNC
Gene Summary: DTX2 functions as an E3 ubiquitin ligase (Takeyama et al., 2003 [PubMed 12670957]).[supplied by OMIM, Nov 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11423 | DTX2 Knockout cell line (HeLa) | Human | DTX2 | 1:3~1:6 | Negative | Online Inquiry |
KO11424 | DTX2 Knockout cell line (HCT 116) | Human | DTX2 | 1:2~1:4 | Negative | Online Inquiry |
KO11425 | DTX2 Knockout cell line (HEK293) | Human | DTX2 | 1:3~1:6 | Negative | Online Inquiry |
KO11426 | DTX2 Knockout cell line (A549) | Human | DTX2 | 1:3~1:4 | Negative | Online Inquiry |
DTX2 Gene Knockout Cell Lines are genetically engineered cell models specifically designed to study the function of the DTX2 gene, which plays a critical role in cellular processes such as apoptosis, cell differentiation, and signal transduction pathways. By utilizing cutting-edge CRISPR-Cas9 technology, these cell lines enable researchers to effectively eliminate the DTX2 gene, creating a knockout model that allows for the observation of cellular behavior in the absence of this gene. This powerful tool facilitates the exploration of various biological mechanisms and the role of DTX2 in disease progression and treatment response.
The primary function of the DTX2 Gene Knockout Cell Lines lies in their capacity to provide insights into cellular processes influenced by the DTX2 gene. By comparing knockout cells with wild-type controls, scientists can investigate downstream effects on signaling pathways and gene expression patterns, elucidating the gene's involvement in critical cellular functions. The knockout cell lines also serve as a foundation for drug screening and therapeutic development, paving the way for advancements in personalized medicine.
In research and clinical settings, these cell lines have significant implications for understanding diseases such as cancer and other proliferative disorders. Given that DTX2 may be involved in tumor development and drug resistance, it presents a valuable target for therapeutic interventions. Researchers looking to dissect the genetic underpinnings of such diseases will find these cell lines indispensable in designing experiments that can lead to novel therapeutic strategies.
One of the key advantages of the DTX2 Gene Knockout Cell Lines is their specificity and reliability. Unlike alternative models that may introduce off-target effects, our precisely engineered cell lines ensure that observed phenotypic changes can be confidently attributed to the absence of DTX2, thus enhancing the robustness of experimental outcomes. Additionally, our product comes with comprehensive support and detailed protocols for optimal use, allowing researchers to streamline their experiments and focus on gaining impactful results.
The value of DTX2 Gene Knockout Cell Lines extends beyond mere experimentation; they represent a significant step forward in cellular research that could lead to breakthrough discoveries in therapeutic development. Our company, with years of expertise in genetic engineering and biological products, is committed to providing high-quality tools that empower researchers and clinicians alike. By choosing our DTX2 Gene Knockout Cell Lines, you are investing in a reliable, innovative resource that can elevate your research and stimulate advancements in biomedical science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.